We serve Chemical Name:cardamom oil CAS:8000-66-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:cardamom oil
CAS.NO:8000-66-6
Synonyms:cardamom oil
Molecular Formula:N/A
Molecular Weight:N/A
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:188 °C(lit.)
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 1993 3/PG 3
Packing Group:
Contact us for information like cardamom oil chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,cardamom oil physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cardamom oil Use and application,cardamom oil technical grade,usp/ep/jp grade.
Related News: The role of a trusted contract development and manufacturing organization (CDMO), with long-standing record of regulatory compliance and efficient project management, can help tremendously in reduced time and costs for the early phase development and commercialization of small molecule active pharmaceutical ingredients (APIs) in the pharmaceutical industry, according to experts. 7H-Purine-6-carboxamide,8,9-dihydro-2-(4-methoxyphenyl)-8-oxo-9-(phenylmethyl)- manufacturers CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 3-Methyl-4-phenyl-cyclopent-2-enone suppliers The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary. Bicyclo[4.4.1]undeca-3,7,9-trien-2-one, (1R)- vendor & factory The CHMP concluded that the benefits of Zynteglo continue to outweigh its risks. As for all medicines, the EMA will monitor any new data on its safety and update advice for patients and healthcare professionals when necessary.,Founded outside Venice in 1949 as a maker of glass bottles for wine and perfume, the firm shifted to glass packaging for the pharmaceutical sector in the early 1970s and later grew to become a leading player in the industry, expanding overseas with new factories in Mexico in 2007 and China in 2012.
